Table 2.
Modified minimum inhibitory concentration of vancomycin, meropenem, and ciprofloxacin upon administration with sCur (8 µg/ml) against MDR pathogens.
Isolates | Vancomycin modified MIC (µg/ml) | Meropenem modified MIC (µg/ml) | Ciprofloxacin modified MIC (µg/ml) |
---|---|---|---|
Staphylococcus aureus (MRSA, 2,862/2019) | 0.25 | – | 1 |
Klebsiella pneumoniae (10,825/2019) | 16 | 2 | 2 |
Escherichia coli (507/2019) | 8 | 1 | 1 |
Pseudomonas aeruginosa (2,412/2019) | 16 | 4 | 2 |